DeepQure
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
DeepQure Strengthens Clinical Leadership with Former SoniVie Executive Appointment 2025-09-03 10:52
MFDS Clears DeepQure's HyperQure™ for Clinical Trial in Atrial Fibrillation 2025-07-18 10:59
DeepQure Advances Global Clinical Trials for Innovative RDN Technology 2025-03-04 09:46
DeepQure Presents Clinical Results of Laparoscopic RDN at TCT 2024, Demonstrating Cutting-edge Technology and Innovation 2024-10-29 21:00
DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension with its Extravascular Renal Denervation Technology (HyperQure™) 2024-06-10 13:14
1